Skip to main content

Table 5 Summary oxygen consumption (VO2, L/min) measures resulting from five upper body power tests

From: Influence of an alkalizing supplement on markers of endurance performance using a double-blind placebo-controlled design

Group

Test

Period

Constant

Power

Test

UBP10

Test

Trial #1

UBP10

Test

Trial #2

UBP10

Test

Trial #3

UBP60

Test

Placebo

(n = 12)

Pre-Test

2.68 ± 0.28

2.29 ± 0.22

2.55 ± 0.20

2.63 ± 0.19

3.14 ± 0.24

 

Post-Test

2.72 ± 0.30

2.47 ± 0.23

2.88 ± 0.23

2.74 ± 0.21

‡3.38 ± 0.26

Treatment

(n = 12)

Pre-Test

2.84 ± 0.29

2.34 ± 0.18

2.61 ± 0.17

2.65 ± 0.19

3.43 ± 0.25

 

Post-Test

†2.77 ± 0.28

2.33 ± 0.21

2.67 ± 0.23

2.68 ± 0.20

‡3.26 ± 0.26

  1. NOTE: All values expressed as Mean ± SE; UBP10 = 10-sec upper body power test; UBP60 = 60-sec upper body power test
  2. †Post-test measure of VO2 for Constant -Power test was nearly significantly lower than pre-test measure within the treatment group (P < 0.10)
  3. ‡Post-test measure of VO2 for UBP60 test were significantly different than pre-test measure within the corresponding test group (P < 0.05)